Scribe Therapeutics Inc (SCTX)

Currency in USD
20.37
-2.64(-11.47%)
Closed·
20.68+0.31(+1.52%)
·
SCTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
20.0423.26
52 wk Range
15.0026.50
Key Statistics
Prev. Close
20.37
Open
23.26
Day's Range
20.04-23.26
52 wk Range
15-26.5
Volume
119.43K
Average Volume (3m)
242.65K
1-Year Change
-
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SCTX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Scribe Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
Jun 12, 2026
EPS / Forecast
-1,19 / --
Revenue / Forecast
2,23M / --
EPS Revisions
Last 90 days

SCTX Income Statement

Compare SCTX to Peers and Sector

Metrics to compare
SCTX
Peers
Sector
Relationship
P/E Ratio
−10.8x−4.6x−0.4x
PEG Ratio
-0.090.00
Price/Book
−2.4x5.0x2.6x
Price / LTM Sales
10.6x7.4x3.1x
Upside (Analyst Target)
-457.9%48.4%
Fair Value Upside
Unlock4.4%6.5%Unlock

Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the root cause of diseases, with a primary focus on cardiometabolic conditions in the United States. The company offers STX-1150 designed to be a single-course in vivo epigenetic silencing treatment targeting the PCSK9 gene; STX-1200 is CRISPR-based gene editing program that aims to offer a permanent solution for patients with elevated Lp(a); and STX-1400 is designed to target and remove the transcriptional start site of the APOC3 gene and strongly reduce mRNA expression. It uses CRISPR-based platforms, such as ELXR, designed for precise, durable epigenetic silencing of genes without changing the underlying DNA sequence; and XE, designed to support specific and efficient gene editing. The company was incorporated in 2017 and is headquartered in Alameda, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
372,35K1,97%8,57M
Other Institutional Investors
19,70M98,03%453,28M
Public Companies & Retail Investors
0,000,00%0,00
Total
20,07M100,00%461,85M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Avoro Capital Advisors LLC16,37%3 088 88871 075
Andreessen Horowitz LLC16,34%3 082 72570 934

FAQ

What Is the Scribe Therapeutics (SCTX) Stock Price Today?

The Scribe Therapeutics stock price today is 20,37 USD.

What Stock Exchange Does Scribe Therapeutics Trade On?

Scribe Therapeutics is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Scribe Therapeutics?

The stock symbol for Scribe Therapeutics is "SCTX."

What Is the Scribe Therapeutics Market Cap?

As of today, Scribe Therapeutics market cap is 384,27M USD.

What Is Scribe Therapeutics's Earnings Per Share (TTM)?

The Scribe Therapeutics EPS (TTM) is -14,64.

From a Technical Analysis Perspective, Is SCTX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Scribe Therapeutics Stock Split?

Scribe Therapeutics has split 0 times.

How Many Employees Does Scribe Therapeutics Have?

Scribe Therapeutics has 89 employees.

What is the current trading status of Scribe Therapeutics (SCTX)?

As of Aug 14, 2026, Scribe Therapeutics (SCTX) is trading at a price of 20,37 USD, with a previous close of 20,37 USD. The stock has fluctuated within a day range of 20,04 USD to 23,26 USD, while its 52-week range spans from 15,00 USD to 26,50 USD.

What Is the SCTX After Hours Price?

SCTX's last after hours stock price is 20,68 USD, the stock has decreased by 0,31, or 1,52%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.